HR Execs on the Move

Genocea

www.genocea.com

 
Genocea is harnessing the power of T cell immunity to develop life-changing vaccines and immunotherapies. While traditional immunotherapy discovery methods have largely used predictive methods to propose T cell targets, or antigens, Genocea has successfully developed ATLAS™, its proprietary technology platform, to identify clinically relevant antigens of T cells based on actual human immune responses. Genocea is currently using ATLAS in immuno-oncology applications to develop neoantigen cancer vaccines, general cancer vaccines and a vaccine targeting cancers caused by Epstein-Barr Virus.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.genocea.com
  • 100 Acorn Park Drive
    Cambridge, MA USA 02140
  • Phone: 617.876.8191

Executives

Name Title Contact Details

Similar Companies

Gemelli Biotech

Gemelli Biotech leverages leading biological discoveries related to the microbiome to provide non-invasive precision diagnostics which enable clinicians to definitively detect scientifically validated biomarkers and optimally treat GI diseases including SIBO, IMO, excess hydrogen sulfide and post-infectious IBS.

BioMarker Strategies

BioMarker Strategies is a Baltimore, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nortern Lipids

Nortern Lipids is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Hibiscus Bioventures

Genomenon

Genomenon is an AI-driven genomics company whose mission is to save and improve lives by making genomic information actionable for patients with rare genetic diseases and cancer.